Search the Newsreel

The Bull Case For Alignment Healthcare (ALHC) Could Change Following Its Top Medicare Advantage Pick Recognition

Alight (ALIT) Q2 2026 Earnings Call Transcript

Is It Too Late to Buy Alignment Healthcare Inc (ALHC) After 3.7% Rally? GF Value Says Undervalued

Alignment Healthcare Inc (ALHC) saw a 3.7% stock rally, yet its current price of $13.96 remains 31.9% below its GF Value™ estimate of $20.50, indicating it is undervalued. Despite a strong GF Score™ of 79/100, driven by excellent growth potential (10/10), the company faces …

ALHC filer Dawn Maroney (ALHC) plans 5,000-share sale after prior 10b5-1 trades

Dawn Maroney, a shareholder associated with Alignment Healthcare (ALHC), has filed a Rule 144 notice to sell 5,000 shares of common stock valued at $67,300 through Morgan Stanley Smith Barney LLC. This planned sale follows several prior 10b5-1 plan sales by Maroney, totaling 237,068 …

Aligos Therapeutics Company Profile & Introduction

This document is intended to provide a company profile and introduction for Aligos Therapeutics. Further details about the company's operations, financial performance, and strategic direction would typically be included in a complete profile.

Align Technology Inc. stock outperforms competitors on strong trading day

Align Technology Inc. (ALGN) saw its stock rise by 2.90% to $181.31, outperforming a generally down market where both the S&P 500 Index and Dow Jones Industrial Average experienced slight declines. This marked the third consecutive day of gains for the company's stock.

A Dozen Universities Allotted Dentistry Research Grants From Align Technology

Align Technology Inc. has awarded 12 research grants to universities globally as part of its Fifteenth Annual Research Award Program. These grants support various dentistry topics, emphasizing Align's commitment to advancing scientific inquiry and innovation in orthodontics and dental care. The funded studies aim …

MetaLight Slashes Headline Loss but Warns on Lower Adjusted Profit Amid Restructuring

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on Behalf of Investors

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results, specifically Adjusted EBITDA. This news led to a significant drop in Alignment Healthcare's stock …

ALHC5941479 Bond Profile — Key Metrics

This article provides key metrics for the ALHC5941479 bond issued by Alignment Healthcare, Inc. The bond has a 4.25% coupon rate and matures on November 15, 2029. Alignment Healthcare is described as a holding company that offers customized healthcare solutions, primarily Medicare Advantage plans, …

Kaplan Fox Urges Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Contact the Firm Regarding a Securities Investigation

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of "accounting irregularities" that "artificially inflated" the company's reported financial results. A whistleblower complaint claims that operating expenses were systematically misclassified as capital expenditures. This news …

Is Alignment Healthcare (ALHC) Undervalued Following Whistleblower Claims And Accounting Investigations?

Align Climbs to No. 1,572 on the 2026 Inc. 5000

Align, a global provider of technology infrastructure solutions and Managed IT Services, has been named to the 2026 Inc. 5000 list for the third consecutive year, ranking at No. 1,572. This marks a significant advancement from its previous rankings, driven by increased demand for …

Invesco Ltd. (ALHC) reports beneficial ownership of 10.4M Alignment Healthcare shares

Invesco Ltd. has reported beneficial ownership of 10,365,640 shares of Alignment Healthcare Inc. common stock, representing 5.0% of the outstanding class. The shares are held by clients of Invesco's advisory entities, with Invesco retaining sole voting power over 9,985,762 shares and sole dispositive power …

Align Technology Inc. stock underperforms Thursday when compared to competitors despite daily gains

Align Technology Inc. (ALGN) stock increased by 1.26% on Thursday, closing at $176.20. Despite this daily gain, the stock underperformed compared to the broader market, as the S&P 500 rose 0.65% and the Dow Jones Industrial Average increased by 0.13%. This marks the second …

Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation Continues

Glancy Prongay Wolke & Rotter LLP is continuing its investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of federal securities law violations. This comes after a whistleblower lawsuit filed by a former executive claimed the company manipulated its finances by misclassifying operating expenses …

Aligos Therapeutics, Inc. (ALGS) Stock Price, News, Quote & History

Align Technology Wins Patent Dispute Against Angelalign in China; Angelalign Plans to Appeal

Align Technology has won a patent infringement lawsuit against Angelalign Technology in China, with the Jinan Intermediate People’s Court ordering Angelalign to cease sales of certain products and pay RMB 10 million in damages. Angelalign plans to appeal the decision, asserting that its products …

Align Technology, Inc. (ALGN) Stock Forecasts

Argus has lowered its target price for Align Technology (ALGN), the leading manufacturer of clear aligners, to $194.00. The company's main product, Invisalign, holds over 90% of the market share. The current stock price for ALGN is $174.01.

Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers

SHANGHAI, Aug. 13, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com said today that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People's Court (Jinan City, China) that directed Angel's Chinese subsidiaries to stop using the masterForce biomechanics simulation …

Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities" artificially inflated the company's financial results. The complaint claims millions in operating expenses were misclassified as capital expenditures, leading to a …

Industry Analysts Just Made A Stunning Upgrade To Their Aligos Therapeutics, Inc. (NASDAQ:ALGS) Revenue Forecasts

Industry analysts have significantly upgraded their revenue forecasts for Aligos Therapeutics, Inc. (NASDAQ:ALGS) for 2026, projecting a 15% improvement in sales to US$36 million, up from a previous estimate of US$22 million. Concurrently, the expected loss per share has been reduced by 46% to …

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Aligos Therapeutics announced that its partner Amoytop has dosed the first participant in a Phase 1 study of ALG-170675 in China. This investigational antisense oligonucleotide (ASO) is designed for the functional cure of chronic hepatitis B virus (HBV) infection, aiming to improve cure rates …

Alight’s (ALIT) Earnings Beat Hides A Shrinking Core, So What Gives?

On August 4, Alight (NYSE:ALIT) posted a second quarter that beat Wall Street's numbers while its core business kept shrinking underneath the headline. Revenue slipped, margins compressed sharply, and adjusted earnings per share were cut nearly in half, yet the results still cleared the …

Align Technology (ALGN): Capital World Investors reports 5% beneficial stake

Capital World Investors, a division of Capital Research and Management Company, has reported a beneficial ownership of 3,571,496 shares of Align Technology, Inc. common stock, which represents 5.0% of the company's outstanding shares. The filing indicates that Capital World Investors holds sole voting power …

Aligos begins phase 1 trial of hepatitis B treatment in China

Aligos Therapeutics Inc. has initiated a Phase 1 study in China for ALG-170675, an antisense oligonucleotide aimed at treating chronic hepatitis B virus infection. This study, conducted in collaboration with Xiamen Amoytop Biotech Co., Ltd., will assess the drug candidate's safety, tolerability, pharmacokinetics, and …

Align Technology (ALGN) Gund-related holders report 5.4% beneficial stake

A group of trusts and individuals related to the Gund family have reported a collective beneficial ownership of 5.4% in Align Technology (ALGN), totaling 3,812,981 shares out of 71,039,852 outstanding shares as of July 31, 2026. Key figures in this group, G. Zachary Gund …

Aligos Begins Testing a Chronic Hepatitis B Candidate in China

Aligos Therapeutics announced that its partner Xiamen Amoytop Biotech has dosed the first participant in a Phase 1 study of ALG-170675 in China. This investigational antisense oligonucleotide aims for a functional cure of chronic hepatitis B virus (HBV) infection. The trial will assess safety, …

Align says Chinese court ruled in its favour in Angelalign patent case

A Chinese court has issued a first-instance ruling in favor of Align Technology in its patent infringement case against Angelalign Technology. The court found that Angelalign infringed Align's patent related to closing extraction gaps using certain digital orthodontic treatment-planning technology and ordered Angelalign to …

Federal Circuit Clarifies Priority Requirements for Prior Art in Dental Monitoring SAS v. Align Technology

The Federal Circuit Court of Appeals clarified the requirements for a U.S. patent publication to serve as prior art based on a provisional application's filing date in *Dental Monitoring SAS v. Align Technology, Inc.* The court ruled that for a patent to claim priority …

Alignment Healthcare (ALHC) Stock Drops 16.7% After Whistleblower Accounting Allegations Trigger Securities Investigation

Shares of Alignment Healthcare (ALHC) dropped 16.7% following the announcement of a securities investigation by Kaplan Fox & Kilsheimer LLP. This investigation stems from a whistleblower complaint by a former executive alleging accounting irregularities, specifically the systematic misclassification of operating expenses as capital expenditures …

Alight Expands Expertise Across Leaves and Consultant Partnerships With Appointment of Three Seasoned Executives

New hires bring deep expertise across clinical operations, delivery transformation and consultant and broker relationships reflective of Alight's continued commitment to service and operational excellence DEERFIELD, Ill., August 12, 2026--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave …

Align Technology Prevails in China Patent Infringement Action

Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China issued a judgment in its favor, in a patent infringement action against Angelalign Technology's operating subsidiaries in China.The company provides an orthodontic treatment system Silver Upgrade to read this MT …